Reverse transcription of 1 μg RNA was performed to synthesize cDNA (Improm II Kit; Promega, Madison, WI). Real-time PCR analysis was performed (Smart Cycler System; Cepheid, Sunnyvale, CA) with dye (SYBR Green I; Cambrex, Washington, DC). The following primers were used: mouse CYP1A1-specific primers, 5′-CACTTGCGGTGCACGATGGAG-3′ and 5′-GTCTAAGCCTGAAGATGC-3′; mouse VEGF-A-specific primers, 5′-CCTGGTGGACATCTTCCAGGAGTACC-3′ and 5′-GAAGCTCATCTCTCCTATGTGCTGGC-3′; mouse VEGF-B-specific primers, 5′-TCTCGCCATCTTTTATCTCCCAG-3′ and 5′-CAGAACCCAAATCCCGTTATTG-3′; mouse β-actin-specific primers, 5′-AGCCTTCCTTCTTGGGTATGG-3′ and 5′-CACTTGCGGTGCACGATGGAG-3′; human CYP1B1-specific primers, 5′-TGCCTGTCACTATTCCTCATG-3′ and 5′-CTTATTGGCAAGTTTCCTTGG-3′; human VEGF-A-specific primers, 5′-ATTGGAGCCTTGCCTTGCTG-3′ and 5′-CACGTCTGCGGATCTTGTAC-3′; and human β-actin-specific primers, 5′-GGGAAATCGTGCGTGACATTAAG-3′ and 5′-TGTGTTGGCGTACAGGTCTTTG-3′. Reaction mixtures were denatured at 95°C for 30 seconds, then subjected to 40 PCR cycles of either 95°C for 3 seconds, 68°C for 30 seconds, and 85°C for 6 seconds for mouse CYP1A1, VEGF-A, VEGF-B, and β-actin or 95°C for 3 seconds and 68°C for 30 seconds for human CYP1B1, VEGF-A, and β-actin. Mouse CYP1A1, VEGF-A, and VEGF-B signals were normalized to mouse β-actin signal, and human CYP1B1 and VEGF-A signals were normalized to human β-actin signal. mRNA expression experiments were performed in triplicate.